The COVID-19 pandemic demonstrated how lateral flow point-of-care (POC) testing can improve target population enrichment and decrease loss of patients to key analysis sets once confirmatory testing becomes available.
Leveraging Technology for Vaccine Trial Surveillance
Vaccine trial sponsors face mounting pressure to accelerate development timelines while upholding the highest standards of data quality and participant safety.
The power of RWD in clinical development and post-market activities
An overview of real-wold data (RWD) and real-world evidence (RWE) and its benefits in drug development and post-market activities with examples of how RWD/RWE supports a product's value throughout the development life cycle.
-
Mumbai, India
